Michelle E. Kruijshaar

3.7k total citations
80 papers, 2.6k citations indexed

About

Michelle E. Kruijshaar is a scholar working on Physiology, Rheumatology and Epidemiology. According to data from OpenAlex, Michelle E. Kruijshaar has authored 80 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Physiology, 34 papers in Rheumatology and 20 papers in Epidemiology. Recurrent topics in Michelle E. Kruijshaar's work include Lysosomal Storage Disorders Research (41 papers), Glycogen Storage Diseases and Myoclonus (34 papers) and Tuberculosis Research and Epidemiology (19 papers). Michelle E. Kruijshaar is often cited by papers focused on Lysosomal Storage Disorders Research (41 papers), Glycogen Storage Diseases and Myoclonus (34 papers) and Tuberculosis Research and Epidemiology (19 papers). Michelle E. Kruijshaar collaborates with scholars based in Netherlands, United Kingdom and United States. Michelle E. Kruijshaar's co-authors include Ibrahim Abubakar, Ans T. van der Ploeg, Pieter A. van Doorn, Jan J. Barendregt, Theo Vos, Gavin Andrews, Jan Spijker, Jonathan E. Moore, Marie‐Louise Essink‐Bot and Nancy Hoeymans and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Michelle E. Kruijshaar

77 papers receiving 2.5k citations

Peers

Michelle E. Kruijshaar
Vahid Ziaee Iran
Isaac Manyonda United Kingdom
Tzu‐Cheg Kao United States
J.A. Stockman United States
Anne Pastuszak Canada
D. M. O. Becroft New Zealand
Steve Shaw United Kingdom
Ninet Sinaii United States
Arnon Elizur Israel
Fulvio Adorni Italy
Vahid Ziaee Iran
Michelle E. Kruijshaar
Citations per year, relative to Michelle E. Kruijshaar Michelle E. Kruijshaar (= 1×) peers Vahid Ziaee

Countries citing papers authored by Michelle E. Kruijshaar

Since Specialization
Citations

This map shows the geographic impact of Michelle E. Kruijshaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle E. Kruijshaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle E. Kruijshaar more than expected).

Fields of papers citing papers by Michelle E. Kruijshaar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle E. Kruijshaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle E. Kruijshaar. The network helps show where Michelle E. Kruijshaar may publish in the future.

Co-authorship network of co-authors of Michelle E. Kruijshaar

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle E. Kruijshaar. A scholar is included among the top collaborators of Michelle E. Kruijshaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle E. Kruijshaar. Michelle E. Kruijshaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beek, Nadine A. M. E. van der, Esther Brusse, Michelle E. Kruijshaar, et al.. (2023). Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. BioDrugs. 37(5). 685–698. 5 indexed citations
2.
Andrinopoulou, Eleni‐Rosalina, et al.. (2023). Association between changes in pulmonary function and in patient reported outcomes during enzyme therapy of adult patients with late‐onset Pompe disease. Journal of Inherited Metabolic Disease. 46(4). 595–604.
3.
Tscherter, Anne, Dominique Baumann, Oswald Hasselmann, et al.. (2022). Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland. Neuromuscular Disorders. 32(5). 399–409. 26 indexed citations
4.
Kanters, Tim A., Ans T. van der Ploeg, Michelle E. Kruijshaar, et al.. (2017). Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease. Orphanet Journal of Rare Diseases. 12(1). 179–179. 17 indexed citations
5.
Kruijshaar, Michelle E., Rick van Minkelen, W. Onkenhout, et al.. (2016). Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations. European Journal of Human Genetics. 24(10). 1424–1429. 18 indexed citations
6.
7.
Zenner, Dominik, Ibrahim Abubakar, Stefano Conti, et al.. (2015). Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. Thorax. 70(6). 566–573. 30 indexed citations
8.
Wens, Stephan C.A., Pierluigi Ciet, Adria Perez‐Rovira, et al.. (2015). Cine-MRI as a New Tool to Evaluate Diaphragmatic Dysfunction in Pompe Disease. Journal of Neuromuscular Diseases. 2(s1). S57–S57. 1 indexed citations
9.
Kanters, Tim A., Ken Redekop, Maureen Rutten‐van Mölken, et al.. (2015). A conceptual disease model for adult Pompe disease. Orphanet Journal of Rare Diseases. 10(1). 112–112. 9 indexed citations
10.
Güngör, Deniz, Michelle E. Kruijshaar, Iris Plug, et al.. (2015). Quality of Life and Participation in the Daily Life (Activities) of Adults with Pompe Disease Receiving Enzyme Replacement Therapy: 10 Years of International Follow-Up. Journal of Neuromuscular Diseases. 2(s1). S63–S63. 1 indexed citations
11.
Vries, Juna M. de, Marianne Hoogeveen‐Westerveld, Stephan C.A. Wens, et al.. (2014). T.P.19. Neuromuscular Disorders. 24(9-10). 870–870. 1 indexed citations
12.
Karabul, Nesrin, et al.. (2014). Pain in adult patients with Pompe disease. Molecular Genetics and Metabolism Reports. 1. 139–140. 5 indexed citations
13.
Zenner, Dominik, Michelle E. Kruijshaar, Nick Andrews, & Ibrahim Abubakar. (2011). Risk of Tuberculosis in Pregnancy: A National, Primary Care–based Cohort and Self-controlled Case Series Study. American Journal of Respiratory and Critical Care Medicine. 185(7). 779–784. 140 indexed citations
14.
Kruijshaar, Michelle E., John Watson, Francis Drobniewski, et al.. (2008). Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data. BMJ. 336(7655). 1231–1234. 28 indexed citations
15.
Kruijshaar, Michelle E., Melissa Kerkhof, PD Siersema, et al.. (2006). The burden of upper gastrointestinal endoscopy in patients with Barrett’s esophagus. Endoscopy. 38(9). 873–878. 46 indexed citations
16.
Kruijshaar, Michelle E., Jan J. Barendregt, Theo Vos, et al.. (2005). Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias. European Journal of Epidemiology. 20(1). 103–111. 174 indexed citations
17.
Kruijshaar, Michelle E.. (2004). The breast cancer related burden of morbidity and mortality in six European countries: The European Disability Weights project. European Journal of Public Health. 14(2). 141–146. 11 indexed citations
18.
Vos, Theo, Michelle M. Haby, Jan J. Barendregt, et al.. (2004). The Burden of Major Depression Avoidable by Longer-term Treatment Strategies. Archives of General Psychiatry. 61(11). 1097–1097. 161 indexed citations
19.
Kruijshaar, Michelle E., Jan J. Barendregt, & Lonneke V. van de Poll‐Franse. (2003). Estimating the prevalence of breast cancer using a disease model: data problems and trends. Population Health Metrics. 1(1). 5–5. 18 indexed citations
20.
Kruijshaar, Michelle E., Nancy Hoeymans, Rob Bijl, Jan Spijker, & Marie‐Louise Essink‐Bot. (2002). Levels of disability in Major Depression. Journal of Affective Disorders. 77(1). 53–64. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vahid Ziaee Breakdown of academic impact, for papers by Isaac Manyonda Breakdown of academic impact, for papers by Tzu‐Cheg Kao Breakdown of academic impact, for papers by J.A. Stockman Breakdown of academic impact, for papers by Anne Pastuszak Breakdown of academic impact, for papers by D. M. O. Becroft Breakdown of academic impact, for papers by Steve Shaw Breakdown of academic impact, for papers by Ninet Sinaii Breakdown of academic impact, for papers by Arnon Elizur Breakdown of academic impact, for papers by Fulvio Adorni
Rankless by CCL
2026